Fundraising FoxKaris Bio
2 known investors
Find your way into Karis Bio
Sign up to see every warm intro you have to Karis Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Karis Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Karis Bio develops therapies based on human induced pluripotent stem cells (hiPSCs) to treat cardiovascular diseases, with initial focus on peripheral arterial disease and critical limb ischemia. The company targets vasculogenesis-related conditions such as ischemic heart disease, diabetic retinopathy, diabetic neuropathy, and wound healing.
Investors · 2
Frequently asked questions
- What does Karis Bio do?
- Karis Bio develops therapies based on human induced pluripotent stem cells (hiPSCs) to treat cardiovascular diseases, with initial focus on peripheral arterial disease and critical limb ischemia. The company targets vasculogenesis-related conditions such as ischemic heart disease, diabetic retinopathy, diabetic neuropathy, and wound healing.
- Who are Karis Bio's investors?
- Karis Bio's investors include Aju IB Investment, Premier Partners.